Ibandronate Sodium

NDC 65862-237 · Aurobindo Pharma Limited

Generic nameIbandronate Sodium

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)IBANDRONATE SODIUM

Strength150 mg/1

Pharmacologic classBisphosphonate [EPC], Diphosphonates [CS]

Marketing categoryANDA

Packages

65862-237-03 — 1 BLISTER PACK in 1 CARTON (65862-237-03) / 3 TABLET, FILM COATED in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

33342-150 — IBANDRONATE SODIUM, 50090-7654 — Ibandronate sodium, 55111-575 — Ibandronate sodium, 55150-191 — Ibandronate Sodium, 60429-643 — IBANDRONATE SODIUM, 60505-6097 — ibandronate sodium, 62756-218 — IBANDRONATE SODIUM, 69452-378 — IBANDRONATE SODIUM

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources